Skip to main content
AAPS Open
Fig. 8 | AAPS Open

Fig. 8

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 8

Dissolution of ~1 mM 200 °C heat-treated Yomesan in nominal pH 9.35 Tris buffer at 23 °C: A 1 to 180 min, final pH 9.32 with logarithmic fit to initial data (dashed line); B comparison between heat-treated Yomesan (black-filled symbols) and untreated Yomesan (gray-filled symbols) from Fig. 4C in 9.35 TB vs time after addition out to day 2 final pH 9.26. Dotted lines are to guide the eye

Back to article page